970O CARBOPLATIN PLUS PACLITAXEL VERSUS CARBOPLATIN PLUS PEGYLATED LIPOSOMAL DOXORUBICIN AS FIRST- LINE TREATMENT FOR PATIENTS WITH OVARIAN CANCER: THE MITO-2 (MULTICENTRE ITALIAN TRIALS IN OVARIAN CANCER) RANDOMIZED PHASE III TRIAL

G. Scambia,A. Savarese,R. Sorio, E. Breda,G. Ferrandina, V. Murgia,S. Tamberi, S. Signoriello, M. Maio, B. Kaufman, J. Lubiński, U. Matulonis, C. Gourley, B. Karlan, D. Taylor, M. Wickens, J. Carmichael, A. Lisyanskaya, S. Rodenhuis, G. Kristensen,E. P. Lauraine, M. Cantarini, U. Emeribe, M. Stuart

semanticscholar（2010）

引用 0|浏览0

暂无评分

摘要

S. Pignata, G. Scambia, A. Savarese, R. Sorio, E. Breda, G. Ferrandina, V. Murgia, S. Tamberi, S. Signoriello, M. Di Maio Uro-Gynecological Department, National Cancer Institute, Naples/ITALY, Department of Gynecologic Oncology, Catholic University of Rome, Rome/ ITALY, Regina Elena Institute, Rome/ITALY, CRO, Aviano/ITALY, Ospedale Fatebenefratelli, Rome/ITALY, Catholic University, Campobasso/ITALY, Ospedale Santa Chiara, Trento/ITALY, Civil Hospital, Faenza/ITALY, Second University, Naples/ITALY, Clinical Trials Unit, National Cancer Institute, Naples/ITALY

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要